Jury orders J & J to pay $550 million in Missouri asbestos cancer case

A Missouri jury on Thursday found Johnson&Johnson liable in a lawsuit filed by 22 women who alleged the company's talc-based products, including J&J Baby Powder, contain asbestos and caused them ovarian cancer, and ordered the company to pay $550 million in compensatory damages.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

This study strengthens the suspicion that, next to germline BAP1 alterations, other genetic factors might predispose families to the development of MM,” the authors wrote. Mutations in only one gene called BAP1 have been shown to increase risk of mesothelioma. However, experts suspect other genes may play a role in the disease. This new study supports the idea that other genes can predispose a person — or even an entire family — to mesothelioma. Hints of Genetic Influence on Mesothelioma Risk Asbestos exposure is the No. 1 cause of mesothelioma. However, some families seem to have more cases of mesothe...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
Conditions:   Peritoneal Mesothelioma;   Fallopian Tube Adenocarcinoma;   Adenocarcinoma of the Ovary;   Primary Peritoneal Carcinoma Intervention:   Biological: MCY-M11 Sponsors:   MaxCyte, Inc.;   CTI Clinical Trial and Consulting Services Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Wall Street is trying to figure out whether the U.S. insurance industry will bear any costs from a record $4.69 billion judgment against Johnson&Johnson awarded to customers and their families who claimed that asbestos-contaminated talc caused ovarian cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Studies conducted in people have mixed results, with some indication of increased risk of ovarian cancer
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Nursing, Oncology, Pathology, Pharmacy, Institutional, Source Type: news
Results of a phase I clinical trial highlight how the addition of a drug to an existing treatment option appears safe and may improve outcomes in certain patients with malignant pleural mesothelioma (MPM). The primary goal of the trial was to determine the maximum tolerated dose of gemcitabine added to cisplatin when these drugs are delivered together as heated intraoperative chemotherapy (HIOC) during surgery. Researchers have studied cisplatin alone for HIOC. The addition of gemcitabine — a chemotherapy drug often used to treat pancreatic, ovarian and breast cancers — is new. The Journal of Thoracic Oncology...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
Johnson&Johnson was ordered to pay $4.7 billion to 22 women and their families who say the company's talcum powder contributed to their ovarian cancer. The New Brunswick, New Jersey-based company (NYS: JNJ) has faced charges that its talc-based products contain asbestos. The trial was brought forward by women who contend that J&J-branded baby powder contained the cancer-causing substance dating back at least to the 1970s. They also contend that J&J knew its talc was contaminated but failed to …
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
A Missouri jury on Thursday found Johnson&Johnson liable in a lawsuit filed by 22 women who alleged the company's talc-based products, including J&J Baby Powder, contain asbestos and caused them ovarian cancer, and ordered the company to pay $550 million in compensatory damages.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news
Johnson&Johnson has vowed to appeal a $4.7 billion verdict awarded to 22 women who claim asbestos-contaminated talc in the company's products gave them ovarian cancer by arguing the plaintiffs' science was flawed and the case should not have been heard in Missouri.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
(CNN) — After 8 hours of deliberations Thursday, a St. Louis jury awarded $4.69 billion to 22 women who sued pharmaceutical giant Johnson &Johnson alleging their ovarian cancer was caused by using its powder as a part of their daily feminine hygiene routine. The jury award includes $550 million in compensatory damages and $4.14 billion in punitive damages. It’s the largest verdict against the company that has sold Baby Powder and Shower to Shower brand talcum powder for decades. The jurors sat through weeks of testimony listening to experts who explained the complicated science, workers at Johnson &John...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News Johnson & Johnson Local TV Source Type: news
A Missouri jury Thursday ordered Johnson &Johnson to pay $4.69 billion to 22 women who claim asbestos in the company’s talc products caused them to develop ovarian cancer. It is the largest verdict to date the consumer goods giant has faced in an asbestos-talc case. The Circuit Court of the City of St. Louis handed down $550 million in compensatory damages and $4.14 billion in punitive damages in the verdict, averaging about $25 million apiece for the 22 plaintiffs. J&J currently faces roughly 9,000 cases that blame its talc products — including the company’s iconic Johnson’s Baby Powder —...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
More News: Asbestosis | Babies | Cancer | Cancer & Oncology | Health | Lawsuits | Legislation | Ovarian Cancer | Ovaries | Women